identification

A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1000 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.

A unique collection of 390 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 2223 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A collection of 17100 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 989 compounds without compro

A collection of 25682 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;

A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;

A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；

Well-chosen 338 GPCR targeting compounds with unique structures;

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2300 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);

Well-chosen 1468 anti-tumor compounds with unique structures;

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening；